Immunological techniques in viral hepatitis Barbara Rehermann, Nikolai V. Naoumov  Journal of Hepatology  Volume 46, Issue 3, Pages 508-520 (March 2007) DOI: 10.1016/j.jhep.2007.01.002 Copyright © 2007 European Association for the Study of the Liver Terms and Conditions

Fig. 1 General considerations for immunological assays. The answers to the indicated questions reflect laboratory practices of “experts” (21 international laboratories including those of the speakers and moderators polled prior to the conference) and those of 170 conference participants. The data in (c) reflect multiple answers per person. Journal of Hepatology 2007 46, 508-520DOI: (10.1016/j.jhep.2007.01.002) Copyright © 2007 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Assays of choice to monitor immune and viral parameters during vaccine and antiviral trials. Conference participants were asked to rank the respective assays (a) and studied parameters (b) from highest to lowest priority. Journal of Hepatology 2007 46, 508-520DOI: (10.1016/j.jhep.2007.01.002) Copyright © 2007 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Conditions for ELISpot and proliferation assays. The answers to the indicated questions reflect laboratory practices of “experts” (21 international laboratories including those of the speakers and moderators polled prior to the conference) and those of 170 conference participants. Journal of Hepatology 2007 46, 508-520DOI: (10.1016/j.jhep.2007.01.002) Copyright © 2007 European Association for the Study of the Liver Terms and Conditions